source
- Medicare delay adds seven years before AbbVie drug price talks, advocacy group saysA consumer advocacy group says a policy change by the Trump administration delayed Medicare’s selection of an AbbVie drug for price negotiations by seven years. The delay occurred as the Centers f…
- Tarsus to acquire eye-drug startup Alkeus in up to $800 million dealTarsus Pharmaceuticals announced Thursday that it will buy Alkeus Pharmaceuticals for up to $800 million, consisting of $270 million in cash and $180 million in stock. The agreement also provides…